In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents

Autores
Alomar, María L.; Rasse-Suriani, Federico; Ganuza, Agustina; Cóceres, Verónica; Cabrerizo, Franco M.; Angel, Sergio Oscar
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Toxoplasmosis is a worldwide infection caused by the protozoan parasite Toxoplasma gondii, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against T. gondii. β-Carbolines (βCs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against T. gondii. Findings: The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5- fold decrease in the invasion rates at doses of 40 μM (harmane and harmine) and 2.5 μM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 μM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites. Conclusions: The three βC alkaloids studied (norharmane, harmane and harmine) exhibit anti-T. gondii effects as evidenced by the partial inhibition of parasite invasion and replication. A dose–response effect was observed at a relatively low drug concentration (< 40 μM), at which no cytotoxic effect was observed on the host cell line (Vero).
Materia
Ciencias Biológicas
Toxoplasma gondii
β-carbolines
drug
invasion
cell cycle
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by/4.0/
Repositorio
CIC Digital (CICBA)
Institución
Comisión de Investigaciones Científicas de la Provincia de Buenos Aires
OAI Identificador
oai:digital.cic.gba.gob.ar:11746/2209

id CICBA_d3689abc43543edcb1c555029fda872d
oai_identifier_str oai:digital.cic.gba.gob.ar:11746/2209
network_acronym_str CICBA
repository_id_str 9441
network_name_str CIC Digital (CICBA)
spelling In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agentsAlomar, María L.Rasse-Suriani, FedericoGanuza, AgustinaCóceres, VerónicaCabrerizo, Franco M.Angel, Sergio OscarCiencias BiológicasToxoplasma gondiiβ-carbolinesdruginvasioncell cycleBackground: Toxoplasmosis is a worldwide infection caused by the protozoan parasite Toxoplasma gondii, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against T. gondii. β-Carbolines (βCs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against T. gondii. Findings: The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5- fold decrease in the invasion rates at doses of 40 μM (harmane and harmine) and 2.5 μM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 μM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites. Conclusions: The three βC alkaloids studied (norharmane, harmane and harmine) exhibit anti-T. gondii effects as evidenced by the partial inhibition of parasite invasion and replication. A dose–response effect was observed at a relatively low drug concentration (< 40 μM), at which no cytotoxic effect was observed on the host cell line (Vero).BioMed Central2013info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttps://digital.cic.gba.gob.ar/handle/11746/2209enginfo:eu-repo/semantics/altIdentifier/doi/10.1186/1756-0500-6-193info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/reponame:CIC Digital (CICBA)instname:Comisión de Investigaciones Científicas de la Provincia de Buenos Airesinstacron:CICBA2025-11-06T09:36:25Zoai:digital.cic.gba.gob.ar:11746/2209Institucionalhttp://digital.cic.gba.gob.arOrganismo científico-tecnológicoNo correspondehttp://digital.cic.gba.gob.ar/oai/snrdmarisa.degiusti@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:94412025-11-06 09:36:25.934CIC Digital (CICBA) - Comisión de Investigaciones Científicas de la Provincia de Buenos Airesfalse
dc.title.none.fl_str_mv In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
title In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
spellingShingle In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
Alomar, María L.
Ciencias Biológicas
Toxoplasma gondii
β-carbolines
drug
invasion
cell cycle
title_short In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
title_full In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
title_fullStr In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
title_full_unstemmed In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
title_sort In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
dc.creator.none.fl_str_mv Alomar, María L.
Rasse-Suriani, Federico
Ganuza, Agustina
Cóceres, Verónica
Cabrerizo, Franco M.
Angel, Sergio Oscar
author Alomar, María L.
author_facet Alomar, María L.
Rasse-Suriani, Federico
Ganuza, Agustina
Cóceres, Verónica
Cabrerizo, Franco M.
Angel, Sergio Oscar
author_role author
author2 Rasse-Suriani, Federico
Ganuza, Agustina
Cóceres, Verónica
Cabrerizo, Franco M.
Angel, Sergio Oscar
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Ciencias Biológicas
Toxoplasma gondii
β-carbolines
drug
invasion
cell cycle
topic Ciencias Biológicas
Toxoplasma gondii
β-carbolines
drug
invasion
cell cycle
dc.description.none.fl_txt_mv Background: Toxoplasmosis is a worldwide infection caused by the protozoan parasite Toxoplasma gondii, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against T. gondii. β-Carbolines (βCs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against T. gondii. Findings: The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5- fold decrease in the invasion rates at doses of 40 μM (harmane and harmine) and 2.5 μM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 μM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites. Conclusions: The three βC alkaloids studied (norharmane, harmane and harmine) exhibit anti-T. gondii effects as evidenced by the partial inhibition of parasite invasion and replication. A dose–response effect was observed at a relatively low drug concentration (< 40 μM), at which no cytotoxic effect was observed on the host cell line (Vero).
description Background: Toxoplasmosis is a worldwide infection caused by the protozoan parasite Toxoplasma gondii, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against T. gondii. β-Carbolines (βCs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against T. gondii. Findings: The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5- fold decrease in the invasion rates at doses of 40 μM (harmane and harmine) and 2.5 μM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 μM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites. Conclusions: The three βC alkaloids studied (norharmane, harmane and harmine) exhibit anti-T. gondii effects as evidenced by the partial inhibition of parasite invasion and replication. A dose–response effect was observed at a relatively low drug concentration (< 40 μM), at which no cytotoxic effect was observed on the host cell line (Vero).
publishDate 2013
dc.date.none.fl_str_mv 2013
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://digital.cic.gba.gob.ar/handle/11746/2209
url https://digital.cic.gba.gob.ar/handle/11746/2209
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1186/1756-0500-6-193
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:CIC Digital (CICBA)
instname:Comisión de Investigaciones Científicas de la Provincia de Buenos Aires
instacron:CICBA
reponame_str CIC Digital (CICBA)
collection CIC Digital (CICBA)
instname_str Comisión de Investigaciones Científicas de la Provincia de Buenos Aires
instacron_str CICBA
institution CICBA
repository.name.fl_str_mv CIC Digital (CICBA) - Comisión de Investigaciones Científicas de la Provincia de Buenos Aires
repository.mail.fl_str_mv marisa.degiusti@sedici.unlp.edu.ar
_version_ 1848045406915657728
score 13.084122